Results
еНаука >
Резултати >
Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients
| Назив: | Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients | Аутори: | Haslemo, Tore; Eliasson, Erik; Jukić, Marin   ; Ingelman-Sundberg, Magnus; Molden, Espen |
Година: | 2019 | Публикација: | British Journal of Clinical Pharmacology | ISSN: | 0306-5251 British Journal of Clinical Pharmacology Претражи идентификатор |
Издавач: | Wiley, Hoboken | Тип резултата: | Научни чланак | Колација: | vol. 85 br. 1 str. 194-201 | DOI: | 10.1111/bcp.13788 | WoS-ID: | 000454096200017 | Scopus-ID: | 2-s2.0-85056270090 | PMID: | 30312494 | URI: | https://enauka.gov.rs/handle/123456789/151628 https://farfar.pharmacy.bg.ac.rs/handle/123456789/3364 |
М-категорија: | 21M21 - Водећи међународни часопис категорије M21 |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.